MicroRNA expression in peripheral blood predicts poor and prolonged response to sunitinib.
Ontology highlight
ABSTRACT: Peripheral blood samples were taken before initiation of therapy and 2 weeks later from patients with advanced renal cell carcinoma treated with sunitinib in first line. MicroRNA expression in peripheral blood was assessed using microarrays and several models predicting poor response and prolonged response to sunitinib were constructed and evaluated.
ORGANISM(S): Homo sapiens
PROVIDER: GSE32099 | GEO | 2013/02/11
SECONDARY ACCESSION(S): PRJNA147553
REPOSITORIES: GEO
ACCESS DATA